The effects of EXOPULSE Mollii Suit in patients with fibromyalgia: a double-blind randomized sham-controlled trial (EXOFIB2) - Top-Institutions - MDSpire

The effects of EXOPULSE Mollii Suit in patients with fibromyalgia: a double-blind randomized sham-controlled trial (EXOFIB2)

  • By

  • Naji Riachi

  • Ahmed Shatila

  • Sehriban Diab

  • Hasan Jaber

  • Mais Jawhari

  • Joseph G Mattar

  • Jean-Pascal Lefaucheur

  • Moussa A Chalah

  • Samar S Ayache

  • January 22, 2026

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Pain Management
    • Neuromodulation

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Pain Medicine
    • Neuromodulation

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Rheumatology
    • Pain Management
    • Physical Medicine and Rehabilitation

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Pain Medicine
    • Neuromodulation

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Rheumatology
    • Pain Research
    • Neuromodulation

Original Source(s)

The effects of EXOPULSE Mollii Suit in patients with fibromyalgia: a double-blind randomized sham-controlled trial (EXOFIB2)

  • by Naji Riachi, Ahmed Shatila, Sehriban Diab, Hasan Jaber, Mais Jawhari, Joseph G Mattar, Jean-Pascal Lefaucheur, Moussa A Chalah, Samar S Ayache

  • January 22, 2026

Related Content

The role of the gut microbiota in the development of rheumatic diseases: a focus on fibromyalgia

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Assessment of Fibromyalgia Symptoms: Frequency and Influencing Factors in an Academic Environment through a Cross-Sectional Analysis